Skip to main content

NutriBand Inc.

corporate_fare Company Profile

NutriBand Inc.

NTRB·NASDAQ·Industrial Applications And Services·CIK 0001676047

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's primary focus is on transdermal products utilizing its proprietary AVERSA™ abuse deterrent transdermal technology. This technology is designed to be integrated into existing transdermal patches containing drugs prone to abuse and misuse, such as opioid and stimulant drugs. Nutriband generates revenue through two distinct subsidiaries. Pocono Pharmaceuticals, operating as Active Intelligence, provides contract manufacturing services for health, wellness, and over-the-counter pharmaceutical clients. The second subsidiary, 4P Therapeutics, offers contract research and development services for pharmaceutical and medical device customers. The company manages and evaluates its financial results through these two subsidiaries. Nutriband's principal offices are located in Orlando, Florida. Its subsidiary, Pocono Pharmaceuticals, operates a manufacturing facility in Cherryville, North Carolina. The company primarily conducts its operations and derives most of its revenues within the United States.

NutriBand Inc. (NASDAQ:NTRB) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors NTRB SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • NutriBand Q3 Revenue Plunges 35% to $433K as Key Customer Shifts Operations
  • Q1 Revenue Declines 35% to $433K, Net Loss Narrows, Going Concern Alleviated with $5M Credit Line Extension
  • Nutriband Subsidiary to Showcase New AI Wellness Products to Walmart, Amazon Buyers at ECRM Conference
  • NutriBand Reports Significant Losses, Internal Control Weaknesses, and Failed Subsidiary Sale; Preferred Stock Dividend Creates Substantial Future Dilution
  • NutriBand Selects Commercial Brand Name for Lead Fentanyl Patch, Advancing Regulatory Path

Financial Snapshot

Fiscal year ended January 31, 2026
Revenue
2.04M
Net Income
-8.23M
Diluted EPS
-2.58
Op. Cash Flow
-5.13M
Free Cash Flow
-5.14M
Gross Profit
566.31K
Operating Income
-8.32M
Cash & Equivalents
4.57M
Debt / Equity
0.00×
Net Margin
-404.1%
Shares Outstanding
12.16M sh
Source: 10-K · filed 2026-05-18 · accession 0001213900-26-058507
Browse all tickers starting with N →
$3.39
52-week range · as of 2026-06-11 $3.21 – $11.68
Market cap
$41.21M
Volume
6.3K (0.6× avg)
3-mo avg 10.9K
Live data · 2026-06-14 03:04 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NTRB - Latest Insights

NTRB
Jun 11, 2026, 4:31 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $3.52
Real-time Price: $3.39 info
Change: -$0.130 (-4%) info
Market Cap: $41.209M info
NTRB
Jun 11, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.52
Real-time Price: $3.39 info
Change: -$0.130 (-4%) info
Market Cap: $41.209M info
NTRB
May 15, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.59
Real-time Price: $3.39 info
Change: -$0.200 (-6%) info
Market Cap: $41.209M info
NTRB
Apr 29, 2026, 5:13 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $3.79
Real-time Price: $3.39 info
Change: -$0.400 (-11%) info
Market Cap: $41.209M info
NTRB
Apr 07, 2026, 3:43 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.81
Real-time Price: $3.39 info
Change: -$0.4209 (-11%) info
Market Cap: $41.209M info
NTRB
Feb 13, 2026, 4:58 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.11
Real-time Price: $3.39 info
Change: -$0.720 (-18%) info
Market Cap: $41.209M info
NTRB
Feb 12, 2026, 5:41 PM EST
Filing Type: 424B3
Importance Score:
9
Price at Filing: $4.06
Real-time Price: $3.39 info
Change: -$0.670 (-17%) info
Market Cap: $41.209M info
NTRB
Feb 03, 2026, 1:44 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.58
Real-time Price: $3.39 info
Change: -$1.19 (-26%) info
Market Cap: $41.209M info